FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Bionpharma Divalproex Sodium Delayed-Release Tablets Recall

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, D…

Bionpharma Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Jul 29, 2026
Recall ID
D-0742-2026
Check your lot numberHow we source this data

Summary

Bionpharma recalled Divalproex Sodium Delayed-Release Tablets starting Jun 26, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0742-2026 on Jul 29, 2026. Reason: Presence of Foreign Tablets/Capsules. Status: Ongoing.

Why it was recalled

Presence of Foreign Tablets/Capsules

Product description

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.

Lot numbers, UPCs & expiration codes

Lot# 704C003, Exp. 12/31/2028

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0742-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 26, 2026
FDA report date
Jul 29, 2026
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Bionpharma Inc.

Original FDA data

Every field from FDA enforcement report D-0742-2026, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
99316
Address
400 Alexander Park Ste 2-4b
Code information
Lot# 704C003, Exp. 12/31/2028
Postal code
08540-6539
Report date
Jul 29, 2026
Product type
Drugs
Recall number
D-0742-2026
Classification
Class II
Recalling firm
Bionpharma Inc.
Reason for recall
Presence of Foreign Tablets/Capsules
Voluntary / mandated
Voluntary: Firm initiated
Product description
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Distribution pattern
US Nationwide.
Recall initiation date
Jun 26, 2026
Initial firm notification
Letter
Center classification date
Aug 6, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0742-2026, published Jul 29, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls